Quick Contact
Disable Preloader

Press Release

ALERT: Drug Suspension and Recall: JUSPRIN 81mg Tablets

17 January 2019


To all patients and healthcare professionals in Bahrain:

Kindly be noted that NHRA has Suspended and Recalled: JUSPRIN 81mg Tablets.  As the product is not bioequivalent to innovator medicine.

SUBSCRIBE TO OUR NEWSLETTER

© Copyrights 2019. National Health Regulatory Authority, Kingdom of Bahrain, All Rights Reserved.